このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Ajanta Pharma Limited 競合他社
価格と性能
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,412.75 |
| 52 Week High | ₹2,540.00 |
| 52 Week Low | ₹1,386.60 |
| Beta | 0.034 |
| 1 Month Change | 0.74% |
| 3 Month Change | 15.88% |
| 1 Year Change | 63.58% |
| 3 Year Change | 85.01% |
| 5 Year Change | 271.44% |
| Change since IPO | 15,304.90% |
最新ニュース
With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Makes An Interesting Case
Jun 01
Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results
May 05Recent updates
With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Makes An Interesting Case
Jun 01Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results
May 05Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price
Apr 05We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease
Feb 23Ajanta Pharma Limited (NSE:AJANTPHARM) Investors Are Less Pessimistic Than Expected
Dec 23Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly
Aug 26These 4 Measures Indicate That Ajanta Pharma (NSE:AJANTPHARM) Is Using Debt Reasonably Well
Feb 07Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors
Oct 24Estimating The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Aug 25Is Now The Time To Put Ajanta Pharma (NSE:AJANTPHARM) On Your Watchlist?
Jul 19A Look At The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Apr 28Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly
Mar 14I Built A List Of Growing Companies And Ajanta Pharma (NSE:AJANTPHARM) Made The Cut
Feb 06Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Dec 13Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50
Oct 31Here's Why We Think Ajanta Pharma (NSE:AJANTPHARM) Is Well Worth Watching
Sep 22Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 27% Discount?
Sep 08Does Ajanta Pharma (NSE:AJANTPHARM) Have A Healthy Balance Sheet?
Aug 26Here's Why Shareholders Will Not Be Complaining About Ajanta Pharma Limited's (NSE:AJANTPHARM) CEO Pay Packet
Jul 07Should You Be Adding Ajanta Pharma (NSE:AJANTPHARM) To Your Watchlist Today?
Jun 14Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 30% Discount?
May 15Ajanta Pharma Limited (NSE:AJANTPHARM) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 10Ajanta Pharma Limited's (NSE:AJANTPHARM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Mar 11Does Ajanta Pharma (NSE:AJANTPHARM) Deserve A Spot On Your Watchlist?
Feb 24The Ajanta Pharma (NSE:AJANTPHARM) Share Price Is Up 56% And Shareholders Are Holding On
Jan 30
What Can We Make Of Ajanta Pharma's (NSE:AJANTPHARM) CEO Compensation?
Jan 18Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Jan 06What Percentage Of Ajanta Pharma Limited (NSE:AJANTPHARM) Shares Do Insiders Own?
Dec 25You Have To Love Ajanta Pharma Limited's (NSE:AJANTPHARM) Dividend
Dec 13Is Ajanta Pharma Limited's (NSE:AJANTPHARM) Recent Stock Performance Influenced By Its Financials In Any Way?
Dec 01With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Is Interesting
Nov 19株主還元
| AJANTPHARM | IN Pharmaceuticals | IN 市場 | |
|---|---|---|---|
| 7D | 1.2% | 0.5% | 2.3% |
| 1Y | 63.6% | 53.0% | 45.0% |
業界別リターン: AJANTPHARM過去 1 年間で56.1 % の収益を上げたIndian Pharmaceuticals業界を上回りました。
価格変動
| AJANTPHARM volatility | |
|---|---|
| AJANTPHARM Average Weekly Movement | 3.9% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.3% |
安定した株価: AJANTPHARM過去 3 か月間に大きな価格変動はありませんでした。
時間の経過による変動: AJANTPHARMの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1973 | 7,713 | Yogesh Agrawal | www.ajantapharma.com |
Ajanta Pharma社は、特殊製剤会社であり、子会社とともに特殊製剤の開発、製造、販売を行っている。同社は、抗マラリア、循環器、眼科、皮膚科、疼痛管理、消化器、抗ヒスタミン、呼吸器、糖尿病など様々な治療分野に製品を供給している。また、錠剤、カプセル剤、粉末剤、液剤、ゼリー剤、軟膏剤、無菌点眼剤、原薬も提供している。同社はインド、アフリカ、その他のアジア、米国、および国際的に事業を展開している。アジャンタ・ファーマ社は1973年に設立され、インドのムンバイに本社を置く。
Ajanta Pharma Limited 基礎のまとめ
| AJANTPHARM 基礎統計学 | |
|---|---|
| 時価総額 | ₹299.51b |
| 収益（TTM） | ₹8.16b |
| 売上高(TTM) | ₹42.09b |
37.2x
PER（株価収益率7.2x
P/SレシオAJANTPHARM は割高か？
公正価値と評価分析を参照収益と収入
| AJANTPHARM 損益計算書（TTM） | |
|---|---|
| 収益 | ₹42.09b |
| 売上原価 | ₹10.67b |
| 売上総利益 | ₹31.42b |
| その他の費用 | ₹23.26b |
| 収益 | ₹8.16b |
直近の収益報告
Mar 31, 2024
次回決算日
該当なし
| 一株当たり利益（EPS） | 64.82 |
| グロス・マージン | 74.66% |
| 純利益率 | 19.39% |
| 有利子負債／自己資本比率 | 0% |
AJANTPHARM の長期的なパフォーマンスは？
過去の実績と比較を見る